Silk Road Medical believes that by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with arterial disease. Our history is one of deep collaboration with vascular surgeons and our future will be guided by continuous learning, observation, and improvement. Silk Road advances patient care. Silk Road Medical Inc. was founded in 2007 and is based in Sunnyvale, California.

Lumen Biomedical, Inc. develops and commercializes interventional devices for embolic protection and thrombus removal throughout the body. It offers FiberNet embolic protection systems for the treatment of patients receiving endovascular intervention for carotid artery diseases; and Xtract, a thrombus aspiration catheter device that supports the care of segment elevation myocardial infarction. The company’s products are used in carotid artery procedures. It serves customers through distributors in the United States and Europe. The company was founded in 2003 and is based in Maple Grove, Minnesota.

Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Zoll Circulation, Inc., a subsidiary of Asahi Kasei Corp., is an American company. The firm manufactures cardiac resuscitation devices.

Minvasys SAS develops and markets medical devices. The firm’s products include Y-connectors, Bifurcation Stents, Stents, Drug Eluting Balloons, PTCA balloons, Thrombo-Aspiration, Embolic protection and Inflation kit. The company was founded in May 2003 and is headquartered in Gennevilliers, France.

Invatec SpA manufactures and distributes vascular interventions and products. It develops and commercializes lesion-specific solutions for coronary and peripheral vascular disease. The company was founded by Andrea Venturelli and Stefan K. Widensohler in 1996 and is headquartered in Roncadelle, Italy.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Nanjing Jingsan Medical Technology Co., Ltd., established on 2017-12-12, Business scope includes medical research and experimental development;medical technology,Technology development of software technology,technology transfer,Technical Services,technical consulting(Do not engage in medical activities);Health Advisory(Do not engage in medical activities,psychological counseling);computer software sales;data processing services;Self-operated and agent import and export business of various commodities and technologies;Class II medical device sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Conference and Exhibition Services;Computer System Services;Information system integration service;Business Management Consulting;Economic and Trade Consulting;advertisement making;advertising;Advertising Design,acting;market survey(Does not include foreign investigations);Organize cultural and artistic exchange activities;Professional Design Services;business training(Does not include education and training,Vocational skills training and other licensed training)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Luoyang Kangli Medical Equipment Co., Ltd., established on 2005-02-24, The business scope includes theIIkind:Medical Ultrasonic Instruments and Related Equipment(6823)Production, sales and import and export trade;Software Development and Sales.

Edwards Lifesciences AG, a subsidiary of Edwards Lifesciences Corp., is a Swiss company located in Nyon that manufactures and distributes healthcare equipment.

Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D., the proven team of innovators and entrepreneurs behind Coridea. The company is backed by top-tier venture investors Third Rock Ventures and SV Life Sciences.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders.\nCoAxia was founded in 1999 by Denise Barbut MD.

Embrella Cardiovascular, Inc. develops a system to enhance embolic cerebral protection, enabling interventionalists to reduce the frequency of embolic strokes during cardiovascular procedures. Embrella Cardiovascular, Inc. is based in Malvern, Pennsylvania.